+ 2.69
+ 0.81%
+ 2.30
+ 0.67%
+ 2.97
+ 0.71%
+ 1.55
+ 0.91%

This Unknown SaaS Business Could Provide An Attractive Opportunity

March 23, 2015 11:29 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Research Solutions Inc (OTCMKTS:RSSS) is a California-based pioneer in providing on-demand access to scientific, technical and medical (STM) information. These include science companies, academic institutions, and research organizations. The company is unique in its Article Galaxy offering, a cloud based software-as-a-service (SaaS) solution, that provides access to tens of millions of existing articles.

This service provides customers with research critical content, while saving time, money and remaining copyright compliant.

The company's main product offering, Article Galaxy has reached an inflection point as strong market adoption is underway. In the 1Q 2015, AG revenue grew 17 percent Y/Y to $5.2 million and in the 2Q 2015 AG revenue increased 19 percent Y/Y to $5.1 million. 

Licensing and copyright fees for AG correlates to a 25 percent gross margin, lower than what is sported by other SaaS offerings, although this GM is higher than the company's legacy reprints business' GM of 10 percent.




Article Galaxy is a game changer in targeting the $5B STM Subscription and Syndication Services market. Historically, AG has target the corporate market with a 4 percent marketshare, but the company is now also targeting the academic market which makes up $4.5 billion of this $5 billion market.

The transition from print to digital is clearly still underway to AG's benefit, and academic institutions' library budgets are under pressure. As such libraries will choose AG to buy single articles, or what they need instead of purchasing entire books.

Related Link: Here's What Else You Should Know About Research Solutions

RSSS is currently undergoing a powerful business transition from its legacy print business with a 9 percent GM to its SaaS Article Galaxy segment which packs a 25 percent GM. This move creates a faster growing and leaner business which can be more profitable on a lower revenue base. The market is unaware of this transition which creates an investment opportunity for investors.

The market is currently unaware of this transition, which creates a buying opportunity for investors.


Article Galaxy


As a SaaS offering, Article Galaxy is the go-to in the industry for STM content. AG has a significant moat since it is an automated process with a highly stickball and stable revenue stream. AG addresses key problems faced by knowledge workers today which include (1) saving time and being a one-stop-shop for STM content, (2) saving money as customers are paying for just the single articles they need, (3) remaining copyright compliant which cuts legal risks and time, (4) AG has checks to ensure no duplicate purchases, and (5) the process is efficient and automated, so paywalls are transcended.

AG's moat with customers and publishers is a strong data point: Article Galaxy ranks number one across every category for customer satisfaction over its peers in a survey by OutSell. AG's customers are stable and include 4/5 of the top 5 drug companies in the world and 50 percent of the global top 10 biotech and pharmaceutical companies.

RSSS also has long-standing partnerships with STM publishers, which streamlines content monetization.


The Most Crucial Element


Management is the most crucial element within a microcap company.

RSSS's CEO Peter Derycz founded Infotrieve and sold the company to PE investors in 2003. Infotrieve is a direct competitor to RSSS, and was acquired by a larger competitor, Copyright Clearance Center or CCC. His considerable experience in this market, coupled with RSSS's moat could make the company a potential buyout target.

There is competition from a number of peers, with Google Inc (NASDAQ: GOOG) Scholar being the main focus.

Image credit: Public Domain

Related Articles

Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1

Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: TSLA) and Nio Inc (NYSE: NIO) in the first quarter and bought shares in vaccine maker Moderna Inc read more

Exclusive: Why Citron Research's Andrew Left Says Jumia Could Be Buyout Target

Citron Research's Andrew Left appeared on Benzinga's YouTube show "PreMarket Prep At The Close" Thursday to discuss Jumia Technologies AG (NYSE: JMIA) in an exclusive interview. read more

Jim Cramer: 'FAANG Owns The Future'

Jim Cramer isn't giving up on FAANG stocks, he said Wednesday night on CNBC's "Mad Money." read more

Could Vuzix's Stock Go Higher After Earnings Next Week?

Leading supplier of smart glasses and augmented reality (AR) technology, Vuzix Corp (NASDAQ: VUZI) does not have any competition in the market, Short Hills Capital Chief Information Officer Steve Weiss said Monday on CNBC's "Fast Money: Halftime Report." read more